IRIS Institutional Research Information System - OPENBS Open Archive UniBS

FREDI, MICAELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.135
AS - Asia 3.508
EU - Europa 2.440
SA - Sud America 682
AF - Africa 100
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.879
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.978
SG - Singapore 1.267
CN - Cina 950
BR - Brasile 575
IT - Italia 509
DE - Germania 421
HK - Hong Kong 407
UA - Ucraina 374
VN - Vietnam 264
BD - Bangladesh 196
FI - Finlandia 195
FR - Francia 192
GB - Regno Unito 184
RU - Federazione Russa 149
TR - Turchia 128
IE - Irlanda 108
IN - India 84
CA - Canada 83
PL - Polonia 80
MX - Messico 47
SE - Svezia 46
AR - Argentina 42
ZA - Sudafrica 36
IQ - Iraq 33
PK - Pakistan 28
NL - Olanda 26
ES - Italia 24
AT - Austria 22
ID - Indonesia 21
JP - Giappone 18
EC - Ecuador 17
MA - Marocco 17
BE - Belgio 14
CZ - Repubblica Ceca 14
LT - Lituania 14
SA - Arabia Saudita 14
KE - Kenya 11
PY - Paraguay 11
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
AU - Australia 9
IL - Israele 9
PH - Filippine 9
UZ - Uzbekistan 9
CO - Colombia 8
KZ - Kazakistan 8
NG - Nigeria 8
MK - Macedonia 7
PT - Portogallo 7
AZ - Azerbaigian 6
DZ - Algeria 6
ET - Etiopia 6
NP - Nepal 6
CL - Cile 5
EG - Egitto 5
GR - Grecia 5
HN - Honduras 5
JO - Giordania 5
MY - Malesia 5
NO - Norvegia 5
RS - Serbia 5
TT - Trinidad e Tobago 5
CH - Svizzera 4
KR - Corea 4
LV - Lettonia 4
PE - Perù 4
TH - Thailandia 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
EU - Europa 3
JM - Giamaica 3
LB - Libano 3
NI - Nicaragua 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AO - Angola 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GT - Guatemala 2
LU - Lussemburgo 2
LY - Libia 2
OM - Oman 2
PA - Panama 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
CY - Cipro 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
Totale 13.861
Salva come PNG Salva come JPEG
Città #
Fairfield 717
Singapore 696
Ashburn 649
Woodbridge 481
Hong Kong 404
San Jose 358
Houston 306
Jacksonville 288
The Dalles 272
Cambridge 266
Beijing 239
Seattle 239
Wilmington 231
Chandler 219
Ann Arbor 213
Los Angeles 203
New York 202
Chicago 197
Princeton 173
Helsinki 143
Dublin 108
Lauterbourg 108
Dallas 104
Istanbul 104
Ho Chi Minh City 82
Salt Lake City 81
Munich 76
Warsaw 76
Nanjing 69
Brescia 68
Hanoi 60
Buffalo 56
Council Bluffs 48
Moscow 48
San Francisco 47
São Paulo 47
Shanghai 46
Redondo Beach 45
London 38
San Diego 36
Des Moines 34
Milan 34
Santa Clara 34
Nanchang 32
Nuremberg 32
Elk Grove Village 31
Orem 30
Tampa 29
Turku 28
Lancaster 27
Montreal 26
Changsha 25
Phoenix 25
Shenyang 25
Johannesburg 24
Brooklyn 23
Chennai 22
Hebei 22
Atlanta 21
Rome 21
Tianjin 21
Mexico City 18
Romola 18
Tokyo 18
Denver 17
Jiaxing 16
Bergamo 15
Frankfurt am Main 15
Brussels 14
Miami 14
Manchester 13
Ottawa 13
Porto Alegre 13
Toronto 13
Cagliari 12
Dong Ket 12
Jinan 12
Rio de Janeiro 12
Stockholm 12
Belo Horizonte 11
Brasília 11
Da Nang 11
Haiphong 11
Hangzhou 11
Sterling 11
Vienna 11
Washington 11
Amsterdam 10
Biên Hòa 10
Dearborn 10
Dhaka 10
Dulles 10
Nürnberg 10
Rozzano 10
Verona 10
Baghdad 9
Campinas 9
Falkenstein 9
Guangzhou 9
Lahore 9
Totale 8.879
Salva come PNG Salva come JPEG
Nome #
Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis 705
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 233
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 233
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 215
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study 205
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 190
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 189
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 186
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 184
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 184
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 180
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 179
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 178
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 177
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 174
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 174
Antiphospholipid antibodies mediate autoimmunity against dying cells. 170
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 169
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 169
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 169
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 164
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 160
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 156
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 156
The clinico-serological spectrum of overlap myositis 156
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 154
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 150
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 145
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 142
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 142
Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome 141
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 140
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. 139
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases 139
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 138
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 138
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 137
IRF5 is associated with primary antiphospholipid syndrome,but is not a major risk factor 133
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 131
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 130
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 128
Belimumab decreases flare rate and hinders the expected damage progression in patients with active systemic lupus erythematosus 127
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 127
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 126
Myositis autoantibodies and clinical phenotypes 125
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 125
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease 124
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 123
Evaluation of a large set of patients with Autoimmune Polyglandular Syndrome from a single reference centre in context of different classifications 119
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 119
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 118
Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis 116
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center 115
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 115
RELATIONSHIP BETWEEN SLE SUSCEPTIBILITY GENES AND CLINICAL MANIFESTATIONS IN A COHORT OF PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME 113
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 112
ANTIPHOSPHOLIPID ANTIBODIES AND CEREBROVASCULAR EVENTS. WHICH FACTORS ASSOCIATE WITH ONSET AND RECURRENCE? - POSTER TOURS 110
Systematic review and meta-analysis of epidemiological studies on the association of occupational exposure to free crystalline silica and systemic lupus erythematosus 106
Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance? 106
Autoimmune polyglandular syndrome type 4: experience from a single reference center 105
Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis 105
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis 105
Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: A multicenter study on 62 pregnancies 105
Should we treat congenital heart block with fluorinated corticosteroids? 102
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options 99
Managing puerperium in patients with systemic autoimmune diseases: an update 98
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry 96
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection 96
Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort 94
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 93
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort. 92
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 92
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 91
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 90
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 88
Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response 88
Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases 86
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 85
Maternal, pregnancy and neonatal outcomes of twin gestations in women with rheumatic diseases: A single-center, case-control study 85
Comparison of Lineblot and Immunoprecipitation Methods in the Detection of Myositis-Specific and Myositis-Associated Antibodies in Patients with Idiopathic Inflammatory Myopathies: Consistency with Clinical Diagnoses 84
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 83
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. 83
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres 82
Evaluation of the incidence of melanoma and non-melanoma skin cancer in patients with systemic lupus erythematosus and systemic sclerosis 79
Neutrophil Extracellular Traps in the Autoimmunity Context. 78
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 78
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 77
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers 76
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 76
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 75
Association of Natural Killer Cell Ligand Polymorphism, HLAC Asn80Lys, with the Development of Anti-SSA/Ro Associated Congenital Heart Block 71
Early echocardiographic alterations in SSc with anti-RNA polymerase III antibodies 71
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 70
Intrauterine fetal deaths related to antiphospholipid syndrome: a descriptive study of 65 women 67
Systemic lupus erythematosus: state of the art on clinical practice guidelines 66
Editorial: Into the heart of systemic autoimmune diseases. 65
Rare clinical manifestations in systemic lupus erythematosus: a review on frequency and clinical presentation 62
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study 62
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study 61
Tapering belimumab in patients with systemic lupus erythematosus: a single-centre experience 61
Totale 12.830
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.917
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022776 67 83 54 41 12 54 26 60 44 95 71 169
2022/2023752 102 7 9 43 74 208 11 90 126 7 35 40
2023/2024927 55 21 79 114 58 151 37 49 198 26 20 119
2024/20252.702 23 38 40 238 195 186 144 92 222 209 579 736
2025/20264.868 402 618 325 672 470 322 685 174 253 454 256 237
2026/202722 22 0 0 0 0 0 0 0 0 0 0 0
Totale 14.104